Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Analysis of Cutaneous Adverse Drug Reactions at a Tertiary Care Hospital - a Prospective Study

S P Shah , M K Desai, R K Dikshit

Department of Pharmacology, B. J. Medical College, Ahmedabad-380016, India;

For correspondence:- S Shah Email: samidhshah@gmail.com Tel:919825507413

Received: 20 October 2010 Accepted: 18 May 2011 Published: 20 August 2011

Citation: Shah SP, Desai MK, Dikshit RK. Analysis of Cutaneous Adverse Drug Reactions at a Tertiary Care Hospital - a Prospective Study. Trop J Pharm Res 2011; 10(4):517-522 doi: 10.4314/tjpr.v10i4.18

© 2011 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To analyze the clinical, pharmacological and economical aspects of the cutaneous adverse drug reactions (ADRs) reported at Civil Hospital, Ahmedabad, India.

Methods: A prospective observational study over a period of one and half years (November 2006 to April 2008) was undertaken. Semi-spontaneous reporting along with a review of case record forms were used. The reports were analyzed for clinical pattern, causal drug groups, causality (WHO-UMC criteria), severity (Hartwig and Siegel scale) and preventability (modified Schumock and Thornton criteria). The cost of ADRs was calculated on the basis of hospital expenditure per patient and the amount spent by patients themselves.

Results: Out of 143 reports, chemotherapeutic agents (39 %) were the most commonly suspected drugs followed by unknown medicines (29 %). Most of the ADRs were designated as possible or probable (69 %) and moderately severe (96.5 %) in nature. However, 14 – 16 % were definitely preventable. Cost incurred by the hospital was Indian national rupees (INR) 374,255, i.e.,USD 8241. While average cost incurred by outpatients was INR 99 (USD 2.18) and that of hospitalized patients was INR 264 (USD 5.81).

Conclusion: A large number of cutaneous ADRs are due to unknown medicines. This calls for strict drug control mechanisms, patient education regarding self-medication and maintenance of prescription records. The cost associated with ADRs is high. ADR monitoring is essential to reduce patient suffering as well as to achieve the substantial savings in health care cost.

Keywords: Cutaneous adverse drug reactions, Cost of ADRs, Preventability, Patient education